INOVIO PHARMACEUTICALS, INC. Cash and Cash Equivalents
INOVIO PHARMACEUTICALS, INC. (INO) had Cash and Cash Equivalents of $31.53 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-12
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $31.53M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $26.27M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $44.27M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $36.57M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $31.53M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $26.27M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $44.27M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $36.57M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $24.35M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $39.92M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $65.81M 10-K · filed 2026-03-12 |
| 2024-09-30 | $21.69M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $34.39M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $19.60M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $14.31M 10-K · filed 2025-03-18 |
| 2023-09-30 | $18.80M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $52.71M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $28.24M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $46.33M 10-K · filed 2024-03-06 |
| 2022-09-30 | $21.99M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $41.10M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $59.01M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $71.14M 10-K · filed 2023-03-01 |
| 2021-09-30 | $67.94M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $58.93M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $83.63M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $250.73M 10-K · filed 2022-03-01 |
| 2020-09-30 | $178.70M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $215.43M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $158.45M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $22.20M 10-K · filed 2021-03-01 |
| 2019-09-30 | $15.85M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $19.74M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $20.78M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $23.69M 10-K · filed 2020-03-12 |
| 2018-09-30 | $19.40M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $15.09M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $37.51M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $23.79M 10-K · filed 2019-03-12 |
| 2017-09-30 | $23.28M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $23.86M 10-Q · filed 2018-08-07 |
| 2017-03-31 | $22.90M 10-Q · filed 2018-05-09 |
| 2016-12-31 | $19.14M 10-K · filed 2019-03-12 |
| 2016-09-30 | $23.25M 10-Q · filed 2017-11-08 |
| 2016-06-30 | $28.45M 10-Q · filed 2017-08-08 |
| 2016-03-31 | $41.62M 10-Q · filed 2017-05-10 |
| 2015-12-31 | $57.63M 10-K · filed 2019-03-12 |
| 2015-09-30 | $85.47M 10-Q · filed 2016-11-09 |
| 2015-06-30 | $70.30M 10-Q · filed 2016-08-08 |
| 2015-03-31 | $26.15M 10-Q · filed 2016-05-09 |
| 2014-12-31 | $40.54M 10-K · filed 2018-03-14 |
| 2014-09-30 | $70.67M 10-Q · filed 2015-11-09 |
| 2014-06-30 | $88.54M 10-Q · filed 2015-08-10 |
| 2014-03-31 | $98.77M 10-Q · filed 2015-05-11 |
| 2013-12-31 | $33.72M 10-K · filed 2017-03-15 |
| 2013-09-30 | $33.07M 10-Q · filed 2014-11-10 |
| 2013-06-30 | $10.35M 10-Q · filed 2014-08-11 |
| 2013-03-31 | $20.09M 10-Q · filed 2014-05-12 |
| 2012-12-31 | $5.65M 10-K · filed 2016-03-14 |
| 2012-09-30 | $4.59M 10-Q · filed 2013-11-12 |
| 2012-06-30 | $5.95M 10-Q · filed 2013-08-09 |
| 2012-03-31 | $11.13M 10-Q · filed 2013-05-10 |
| 2011-12-31 | $17.35M 10-K · filed 2015-03-16 |
| 2011-09-30 | $25.30M 10-Q · filed 2012-11-07 |
| 2011-06-30 | $30.59M 10-Q · filed 2012-08-09 |
| 2011-03-31 | $37.18M 10-Q · filed 2012-05-09 |
| 2010-12-31 | $20.00M 10-K · filed 2014-03-17 |
| 2010-09-30 | $19.39M 10-Q · filed 2011-11-07 |
| 2010-06-30 | $14.95M 10-Q · filed 2011-08-05 |
| 2009-12-31 | $30.30M 10-K · filed 2013-03-18 |
| 2008-12-31 | $14.12M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |